Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Järjestys:
Keyphrases
After Surgery
11%
Age Groups
5%
Aggregate Data
7%
Androgen Deprivation Therapy
22%
ARAMIS
7%
Bladder Cancer
5%
Breast Cancer
7%
Cancer Mortality
7%
Cancer-related
6%
Castration-resistant Prostate Cancer
13%
Clinical Outcomes
5%
Clinically Significant Prostate Cancer
5%
Comorbidity
6%
Confidence Interval
21%
Darolutamide
12%
Economic Factors
5%
Elderly Patients
7%
EPIC-26
9%
Europe
9%
European Randomized Study of Screening for Prostate Cancer
10%
Euthyroid
11%
Expanded Prostate Cancer Index Composite
8%
Finland
27%
Functional Outcome
7%
Geoeconomics
5%
Hazard Ratio
11%
High-grade Prostate Cancer
13%
Hypothyroid
5%
Hypothyroidism
13%
International Survey
8%
Laparoscopic Radical Prostatectomy
11%
Levothyroxine
5%
Long Non-coding RNA (LncRNA)
7%
Lower Urinary Tract Symptoms
7%
Lymph Node Metastasis
6%
Lynch Syndrome
7%
Magnetic Resonance Imaging
9%
Metastasis
5%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
14%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
8%
Multivariable
5%
Non-associated
5%
Non-muscle Invasive Bladder Cancer (NMIBC)
5%
Nonmetastatic Prostate Cancer
5%
Oncological Outcomes
7%
Overall Survival
17%
Patients with Prostate Cancer
11%
Placebo
5%
Population-based Cohort Study
5%
Prognostic Factors
9%
Prostate
13%
Prostate Cancer
72%
Prostate Cancer Patients
13%
Prostate Cancer Risk
29%
Prostate Cancer Screening
26%
Prostate Radiotherapy
9%
Prostate-specific Antigen
13%
Prostate-specific Antigen Testing
7%
Prostatectomy
8%
Quality of Life
7%
Radical Prostatectomy
11%
Random Forest Algorithm
5%
Randomized Controlled Trial
9%
Randomized Trial
8%
Reoperation
5%
Risk Factors
8%
Risk of Death
8%
Robot-assisted
7%
Sensitivity Analysis
5%
Statin Use
11%
Statins
7%
Tampere
5%
Testosterone
7%
Three-dimensional (3D)
11%
Thyroid Hormones
7%
Tolerability
9%
Total Prostate-specific Antigen
8%
University Hospital
7%
Urinary Incontinence
5%
Visual Analog Scale
5%
Well-being
5%
Medicine and Dentistry
Androgen Deprivation Therapy
20%
Androgen Receptor
7%
Arm
8%
Biopsy Technique
5%
Cancer Cell
6%
Cancer Mortality
18%
Cancer Screening
12%
Cancer Therapy
7%
Castration Resistant Prostate Cancer
8%
Clear Cell Renal Cell Carcinoma
11%
Cohort Analysis
6%
Comorbidity
5%
Continence
8%
Cystectomy
7%
Diseases
7%
Elderly Patient
7%
Gene Expression
7%
Hazard Ratio
6%
Hereditary Nonpolyposis Colorectal Cancer
7%
Hypothyroidism
12%
Levothyroxine
5%
Liotrix
11%
Lymph Node Metastasis
6%
Magnetic Resonance Imaging
12%
Malignant Neoplasm
8%
Medical Record
5%
Neoplasm
8%
Overall Survival
8%
Prognostic Factor
8%
Prostate Cancer
100%
Prostate Specific Antigen
15%
Prostatectomy
26%
Quality of Life
7%
Randomized Controlled Trial
15%
Recurrent Disease
6%
Reoperation
5%
Robot-Assisted Prostatectomy
8%
Screening of Prostate Cancer
8%
Thyroid Gland
16%
Thyroid Hormone
7%
Urinary System
7%
Visual Analog Scale
5%